- Home
- ENIC vs OGN Comparison
ENIC vs OGN Comparison
Compare ENIC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENIC
- OGN
- Stock Information
- Founded
- ENIC 2016
- OGN 1923
- Country
- ENIC Chile
- OGN United States
- Employees
- ENIC N/A
- OGN N/A
- Industry
- ENIC Electric Utilities: Central
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- ENIC Utilities
- OGN Health Care
- Exchange
- ENIC Nasdaq
- OGN Nasdaq
- Market Cap
- ENIC 3.7B
- OGN 3.9B
- IPO Year
- ENIC N/A
- OGN N/A
- Fundamental
- Price
- ENIC $2.95
- OGN $14.50
- Analyst Decision
- ENIC Hold
- OGN Hold
- Analyst Count
- ENIC 1
- OGN 3
- Target Price
- ENIC $3.90
- OGN $21.33
- AVG Volume (30 Days)
- ENIC 404.9K
- OGN 4.5M
- Earning Date
- ENIC 10-29-2024
- OGN 02-13-2025
- Dividend Yield
- ENIC 8.44%
- OGN 7.68%
- EPS Growth
- ENIC N/A
- OGN 120.97
- EPS
- ENIC 0.01
- OGN 5.04
- Revenue
- ENIC $5,287,759,941.00
- OGN $6,409,000,000.00
- Revenue This Year
- ENIC $16.86
- OGN $3.11
- Revenue Next Year
- ENIC N/A
- OGN $2.55
- P/E Ratio
- ENIC $4.65
- OGN $2.89
- Revenue Growth
- ENIC 8.81
- OGN 4.21
- 52 Week Low
- ENIC $2.51
- OGN $13.58
- 52 Week High
- ENIC $3.41
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- ENIC 62.85
- OGN 37.20
- Support Level
- ENIC $2.74
- OGN $14.39
- Resistance Level
- ENIC $2.90
- OGN $15.15
- Average True Range (ATR)
- ENIC 0.07
- OGN 0.52
- MACD
- ENIC 0.01
- OGN -0.02
- Stochastic Oscillator
- ENIC 90.57
- OGN 8.63
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.